×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RDY – dr. reddy's laboratories ltd (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RDY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
08:26 am
rdy
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at Nomura from a "buy" rating to a "neutral" rating.
Low
Report
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at Nomura from a "buy" rating to a "neutral" rating.
12/13
11:32 am
rdy
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
Low
Report
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
12/11
06:04 pm
rdy
Heparin Market to Grow by USD 3.34 Billion (2024-2028), Driven by Coagulation Disorder Prevalence and AI Impacting Market Trends - Technavio [Yahoo! Finance]
Low
Report
Heparin Market to Grow by USD 3.34 Billion (2024-2028), Driven by Coagulation Disorder Prevalence and AI Impacting Market Trends - Technavio [Yahoo! Finance]
12/10
08:20 am
rdy
Theranica Advances Migraine Care in 2024 Supported by New Research, an Expanded Indication, a new Chief Medical Officer, and Broader Insurance Coverage [Yahoo! Finance]
Low
Report
Theranica Advances Migraine Care in 2024 Supported by New Research, an Expanded Indication, a new Chief Medical Officer, and Broader Insurance Coverage [Yahoo! Finance]
12/6
11:02 pm
rdy
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
12/4
07:15 am
rdy
Coccidioidomycosis Drugs Market to Reach US$ 634.3 Million by 2034, Expanding at a CAGR of 4.9% | Fact.MR Report [Yahoo! Finance]
Low
Report
Coccidioidomycosis Drugs Market to Reach US$ 634.3 Million by 2034, Expanding at a CAGR of 4.9% | Fact.MR Report [Yahoo! Finance]
12/2
11:49 am
rdy
Here's Why You Should Add Dr. Reddy's Stock to Your Portfolio [Yahoo! Finance]
Low
Report
Here's Why You Should Add Dr. Reddy's Stock to Your Portfolio [Yahoo! Finance]
11/29
12:04 pm
rdy
RDY Launches Loqtorzi Biosimilar in India for Nasopharyngeal Carcinoma [Yahoo! Finance]
Low
Report
RDY Launches Loqtorzi Biosimilar in India for Nasopharyngeal Carcinoma [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2024
04:03 pm
rdy
dr. reddy's laboratories ltd
BEAT
Report
-0.7%
dr. reddy's laboratories ltd
11/5/2024
04:02 pm
rdy
dr. reddy's laboratories ltd
BEAT
Report
0.3%
dr. reddy's laboratories ltd
7/29/2024
04:01 pm
rdy
dr. reddy's laboratories ltd
BEAT
Report
-1.1%
dr. reddy's laboratories ltd
7/28/2024
06:05 pm
rdy
dr. reddy's laboratories ltd
BEAT
Report
-1.1%
dr. reddy's laboratories ltd
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/20
06:54 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Dec 20
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Dec 20
12/6
07:41 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Dec 06
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Dec 06
12/6
06:12 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Dec 05
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Dec 05
12/3
06:16 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Dec 03
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Dec 03
12/2
06:29 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Dec 01
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Dec 01
11/29
06:19 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Nov 28
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Nov 28
11/27
08:39 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Nov 27
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Nov 27
11/26
06:20 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Nov 26
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Nov 26
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Dr.Reddy's Laboratories Ltd (NYSE: RDY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating.
6.2%
1/27 Form 6-K DR REDDYS LABORATORIES For: Jan 27 5.3%
4/9 Form SC 13G/A DR REDDYS LABORATORIES Filed by: BlackRock Inc. 4.8%
3/20 Dr. Reddy's launches pyrimethamine tablets in U.S. [Seeking Alpha] 3.9%
3/17 Dr. Reddy's Laboratories announces the launch of Ziprasidone Mesylate for Injection in the U.S. Market 3.0%
10/23 Dr. Reddy’s Confirms Its Voluntary Nationwide Recall of All Ranitidine Products in the U.S. Market 2.8%
7/29 Dr. Reddy's Laboratories Limited 2020 Q1 - Results - Earnings Call Slides [Seeking Alpha] 2.8%
9/11 Hazmat situation reported at Dr. Reddy's New York facility [Seeking Alpha] 2.8%
5/20 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A 2.7%
9/9 Form SC 13G DR REDDYS LABORATORIES Filed by: COMMONWEALTH BANK OF AUSTRALIA 2.4%
1/27 Form 6-K DR REDDYS LABORATORIES For: Jan 27 5.3%
4/9 Form SC 13G/A DR REDDYS LABORATORIES Filed by: BlackRock Inc. 4.8%
3/20 Dr. Reddy's launches pyrimethamine tablets in U.S. [Seeking Alpha] 3.9%
3/17 Dr. Reddy's Laboratories announces the launch of Ziprasidone Mesylate for Injection in the U.S. Market 3.0%
10/23 Dr. Reddy’s Confirms Its Voluntary Nationwide Recall of All Ranitidine Products in the U.S. Market 2.8%
7/29 Dr. Reddy's Laboratories Limited 2020 Q1 - Results - Earnings Call Slides [Seeking Alpha] 2.8%
9/11 Hazmat situation reported at Dr. Reddy's New York facility [Seeking Alpha] 2.8%
5/20 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A 2.7%
9/9 Form SC 13G DR REDDYS LABORATORIES Filed by: COMMONWEALTH BANK OF AUSTRALIA 2.4%
TOP News Decliners
3/12
Form 6-K DR REDDYS LABORATORIES For: Mar 12
-6.6%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -6.0%
3/16 Form 6-K DR REDDYS LABORATORIES For: Mar 14 -4.6%
7/29 Dr. Reddy’s Q1 FY20 Financial Results -3.3%
7/29 Q1/2020 6/30/2019 EPS 39.910 ZacksConsensus N/A ActVsEst N/A - N/A -2.9%
7/23 Form 6-K DR REDDYS LABORATORIES For: Jul 23 -2.5%
2/27 Dr. Reddy's Laboratories Announces the First Generic Launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market -2.3%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -1.9%
10/23 Dr. Reddy's is recalling some products used to treat heartburn [CNN] -1.8%
11/22 Dr. Reddy's Laboratories announces launch of Doxercalciferol Injection in the U.S. Market -1.7%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -6.0%
3/16 Form 6-K DR REDDYS LABORATORIES For: Mar 14 -4.6%
7/29 Dr. Reddy’s Q1 FY20 Financial Results -3.3%
7/29 Q1/2020 6/30/2019 EPS 39.910 ZacksConsensus N/A ActVsEst N/A - N/A -2.9%
7/23 Form 6-K DR REDDYS LABORATORIES For: Jul 23 -2.5%
2/27 Dr. Reddy's Laboratories Announces the First Generic Launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market -2.3%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -1.9%
10/23 Dr. Reddy's is recalling some products used to treat heartburn [CNN] -1.8%
11/22 Dr. Reddy's Laboratories announces launch of Doxercalciferol Injection in the U.S. Market -1.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: